John W. Martin
Corporate Officer/Principal bij The European Commission
Profiel
John W.
Martin was the founder of Ark Therapeutics Group Plc, which was founded in 1997, where he held the title of Chief Scientific Officer from 1997 to 2010.
Currently, he is the Chairman of Cardiovascular Medicine at University College London and the Chairman of the Expert Cardiovascular Committee at The European Commission.
In the past, he held the position of Member of the Animal Procedures Committee at the United Kingdom Ministry of Home Affairs from 1998 to 2006, Head of Pharmacology & Cardiovascular Research at Wellcome Research Laboratories from 1986 to 1996, and Vice President at The European Society of Cardiology in 2002.
Actieve functies van John W. Martin
| Bedrijven | Functie | Begin |
|---|---|---|
| The European Commission | Corporate Officer/Principal | 25-11-2010 |
| University College London | Corporate Officer/Principal | - |
Eerdere bekende functies van John W. Martin
| Bedrijven | Functie | Einde |
|---|---|---|
| United Kingdom Ministry of Home Affairs | Corporate Officer/Principal | 01-01-2006 |
| The European Society of Cardiology | Corporate Officer/Principal | 01-01-2002 |
| Wellcome Research Laboratories | Hoofd Techniek/Wetenschap/O&O | 01-01-1996 |
Ark Therapeutics Group Plc
 Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Commercial Services |
| Wellcome Research Laboratories | |
| The European Society of Cardiology | |
| United Kingdom Ministry of Home Affairs | Government |
| The European Commission | Government |
